We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Bio-Expandable Bone Graft Could Help Spinal Surgery Patients

By HospiMedica International staff writers
Posted on 13 Apr 2016
An expandable, biodegradable graft could help metastatic spinal tumor patients recover from the surgical removal of bone segments and intervertebral discs, according to a new study.

Researchers at the Mayo Clinic (Rochester, MN, USA) have developed a biodegradable, hydrophilic, polymer graft that when surgically placed in the damaged vertebrae, expands to precisely fill the resected areas by absorbing bodily fluids. More...
The graft is composed of two sections; a hollow hydrophilic scaffold made of crosslinked oligo(poly(ethylene glycol) fumarate) (OPF), and a stabilized polymer filler material. To develop the graft, the researchers first identified a combination of materials that are biocompatible in animals, and which they believe will work in humans.

To control the kinetics of the polymer graft expansion, the researchers made chemical changes to the filler to modify the degree and timing of the expansion, under conditions that mimicked the spinal column environment. The modulation of the molecular weight and charge of the polymer enabled them to tune the material’s properties so that the expansion rate was slow enough to enable surgeons to place it correctly, but fast enough so that it did not extend surgery times. The study was presented at the 251st national meeting & exposition of the American Chemical Society (ACS), held during March 2016 in San Diego (CA, USA).

“The overall goal of this research is to find ways to treat people with metastatic spinal tumors; the spine is the most common site of skeletal metastases in cancer patients, but unlike current treatments, our approach is less invasive and is inexpensive,” said lead author and study presenter Lichun Lu, PhD. “When we designed this expandable tube, we wanted to be able to control the size of the graft so it would fit into the exact space left behind after removing the tumor.”

Related Links:

Mayo Clinic



Gold Member
Blood Gas Analyzer
i-Check200
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Resorbable Bovine Collagen Membrane
GenDerm
Medical Adhesive
MED 5570U
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: 123RF

AI Platform Screens for Amyloid Cardiomyopathy Using ECG Images

Amyloid cardiomyopathy is a heart disease caused by deposits of misfolded proteins in the cardiac muscle. It is often missed until patients develop serious complications such as heart failure.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.